Carlo Bruno Giorda (C B Giorda, Carlo B Giorda, Carlo Giorda)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 18

Top Venues

Acta diabetologica

Diabetes/metabolism research and reviews

Diabetes therapy : research, treatment and education of diabetes and related disorders

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

A Piatti, F Romeo, R Manti, M Doglio, B Tartaglino, E Nada, Carlo Bruno Giorda
Feasibility and accuracy of the screening for diabetic retinopathy using a fundus camera and an artificial intelligence pre-evaluation application. Acta diabetologica (2023)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Correction to: Increased incidence of type 1 diabetes in 2 years of COVID‑19 pandemic. Acta diabetologica (2023)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Correction to: Increased incidence of type 1 diabetes in 2 years of COVID‑19 pandemic. Acta diabetologica (2023)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Lucia Favella, Francesco Romeo, Alessandro Migliardi, Silvia Ferro, Ivana Rabbone
An update on the incidence of type 1 diabetes during the COVID-19 pandemic years. Diabetes, obesity & metabolism (2023)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Correction to: Increased incidence of type 1 diabetes in 2 years of COVID‑19 pandemic. Acta diabetologica (2023)
Carlo Bruno Giorda, Roberta Picariello, Tania Landriscina, Barbara Tartaglino, Elisa Nada, Marella Doglio, Francesco Romeo, Roberto Gnavi
Instructive lessons from the analysis of assistance in diabetes during the first phase of COVID-19 pandemic. Acta diabetologica 59 (6) (2022)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica 60 (4) (2022)
Carlo Bruno Giorda, Gnavi Roberto, Tartaglino Barbara, Manti Roberta, Migliardi Alessandro, Favella Lucia, Ferro Silvia, Rabbone Ivana
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica (2022)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica 60 (4) (2022)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica 60 (4) (2022)
Carlo Bruno Giorda, Roberto Gnavi, Barbara Tartaglino, Roberta Manti, Alessandro Migliardi, Lucia Favella, Silvia Ferro, Ivana Rabbone
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica (2022)
Carlo Bruno Giorda, Gnavi Roberto, Tartaglino Barbara, Manti Roberta, Migliardi Alessandro, Favella Lucia, Ferro Silvia, Rabbone Ivana
Increased incidence of type 1 diabetes in 2 years of COVID-19 pandemic. Acta diabetologica (2022)
Carlo Bruno Giorda, Federico Pisani, Alberto De Micheli, Paola Ponzani, Giuseppina Russo, Giacomo Guaita, Rita Zilich, Nicoletta Musacchio, null null
Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysis. BMJ open diabetes research & care 8 (1) (2021)
Carlo Bruno Giorda, Emanuela Orsi, Salvatore De Cosmo, Antonio Carlo Bossi, Catia Guerzoni, Stefania Cercone, Barbara Gilio, Franco Cavalot
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) Study. Diabetes therapy : research, treatment and education of diabetes and related disorders 11 (9) (2020)
Carlo Bruno Giorda, Roberta Picariello, Barbara Tartaglino, Elisa Nada, Giuseppe Costa, Roberto Gnavi
Incretin-based therapy and risk of cholangiocarcinoma: a nested case-control study in a population of subjects with type 2 diabetes. Acta diabetologica 57 (4) (2019)
Antonio Ceriello, Maria Chiara Rossi, Salvatore De Cosmo, Giuseppe Lucisano, Roberto Pontremoli, Paola Fioretto, Carlo Bruno Giorda, Antonio Pacilli, Francesca Viazzi, Giuseppina Russo, Antonio Nicolucci, null null
Overall Quality of Care Predicts the Variability of Key Risk Factors for Complications in Type 2 Diabetes: An Observational, Longitudinal Retrospective Study. Diabetes care 42 (4) (2019)
Carlo Bruno Giorda, Paolo Carnà, Mario Salomone, Roberta Picariello, Giuseppe Costa, Barbara Tartaglino, Roberto Gnavi
Ten-year comparative analysis of incidence, prognosis, and associated factors for dialysis and renal transplantation in type 1 and type 2 diabetes versus non-diabetes. Acta diabetologica 55 (7) (2018)
Carlo Bruno Giorda, Gabriele Forlani, Roberta Manti, Natalia Mazzella, Salvatore De Cosmo, Maria Chiara Rossi, Antonio Nicolucci, Giuseppina Russo, Paolo Di Bartolo, Antonio Ceriello, Piero Guida, null null
Occurrence over time and regression of nonalcoholic fatty liver disease in type 2 diabetes. Diabetes/metabolism research and reviews 33 (4) (2017)

Carlo Bruno Giorda.css-eqlu8i{font-size:small;padding-left:4px;} (C B Giorda, Carlo B Giorda, Carlo Giorda)

Publication Activity (10 Years)

Top Topics

Top Venues

Carlo Bruno Giorda (C B Giorda, Carlo B Giorda, Carlo Giorda)